Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Study of Alfimeprase for Occluded Central Venous Access Devices
2005-003282-16Phase 3Completed
- Sponsor
- Nuvelo
- Start
- Sep 2005
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in catheter occlusion comparing Alfimeprase with Placebo (2 arms). Primary endpoint: Primary catheter function restoration at 15 minutes. Started Sep 2005; status: completed.
02
Drugs
alfimeprase
03
Conditions
catheter occlusion
Beyond the preview
Go deeper on 2005-003282-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003282-16.